Literature DB >> 2033490

Distribution of beta 1, alpha 1, alpha 2 and alpha 3 integrin chains in basal cell carcinomas.

G W Stamp1, M Pignatelli.   

Abstract

The integrins are alpha beta heterodimeric transmembrane proteins mediating cell-substratum as well as cell-cell interactions. Changes in their expression and/or function seem to occur in a number of malignant epithelial neoplasms and may in part explain their abnormal patterns of growth and differentiation. Using monoclonal antibodies to the beta 1 (DH12), alpha 1 (TS2/7), alpha 2 (B1.515), and alpha 3 (E1.56) integrin chains, the alpha 1 beta 1 (VLA-1), alpha 2 beta 1 (VLA-2), and alpha 3 beta 1 (VLA-3) integrin receptors were studied on cryostat sections of 22 basal cell carcinomas (BCCs) and adjacent normal tissues by a standard peroxidase-antiperoxidase technique. In non-neoplastic skin, VLA-2 and VLA-3 were found in the basal layer, eccrine glands, and cells of the outer root sheath in which VLA-1 was detected. In BCCs, there was a considerably higher expression of VLA-2 and VLA-3 compared with epidermal basal cells but similar to that seen in hair bulb and outer root sheath. In two cases of nodular BCC showing evidence of regression, both VLA-2 and VLA-3 were completely negative, in contrast to non-regressing foci which were strongly positive. The high level of expression of two adhesion molecules (VLA-2 and VLA-3) involved in cell-substratum as well as cell-cell interactions may account for the more indolent pattern of growth characteristic of BCC and perhaps reflect its high degree of differentiation towards the hair follicle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2033490     DOI: 10.1002/path.1711630407

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  17 in total

1.  Characterization of integrin receptors in normal and neoplastic human brain.

Authors:  W Paulus; I Baur; D Schuppan; W Roggendorf
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

Review 2.  Current concepts in metastasis.

Authors:  A K Nigam; M Pignatelli; P B Boulos
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

3.  Cell adhesion molecules in oesophageal epithelium.

Authors:  H Dobson; M Pignatelli; D Hopwood; C D'Arrigo
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

Review 4.  Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors.

Authors:  M M Zutter; H Sun; S A Santoro
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

5.  Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance.

Authors:  Jian-Min Su; Lu Gui; Yi-Ping Zhou; Xi-Liang Zha
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

6.  Integrins as differential cell lineage markers of primary liver tumors.

Authors:  R Volpes; J J van den Oord; V J Desmet
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  The tumor microenvironment: possible role of integrins and the extracellular matrix in tumor biological behavior of intratubular germ cell neoplasia and testicular seminomas.

Authors:  A Timmer; J W Oosterhuis; H Schraffordt Koops; D T Sleijfer; B G Szabo; W Timens
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

8.  Expression of the VLA beta 1 integrin family in bladder cancer.

Authors:  M Liebert; R Washington; J Stein; G Wedemeyer; H B Grossman
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Distribution of integrin cell adhesion molecules in endometrial cancer.

Authors:  B A Lessey; S Albelda; C A Buck; A J Castelbaum; I Yeh; M Kohler; A Berchuck
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

Review 10.  Adhesion Molecules in Non-melanoma Skin Cancers: A Comprehensive Review.

Authors:  Joanna Pogorzelska-Dyrbus; Jacek C Szepietowski
Journal:  In Vivo       Date:  2021-04-28       Impact factor: 2.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.